ANZEN PHARMACEUTICALS
Live / Allowed — Notice of allowance issued (as of 03 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98629944
- Mark type
- Stylized text
- Filed
- 02 Jul 2024
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Kevin Michael Strait
Goods and services
- Class 005 — Pharmaceuticals: Acetaminophen; Analgesic preparations; Analgesics; Pain relief medication; Antipyretic analgesics; Oral analgesics; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Preparation for the relief of pain
- Class 042 — Scientific and technological services: Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Providing scientific research information in the field of pharmaceuticals; Research on the subject of pharmaceuticals
Owner
- Anzen Pharmaceuticals Corporation, Fort Collins, CO, US
- Anzen Pharmaceuticals Corporation, Fort Collins, CO, US
Prior registrations
Prosecution history
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Nov 2025 — ASSIGNED TO LIE
- 02 Nov 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 09 Sept 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 25 Jul 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 24 Jan 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 Jan 2025 — LETTER OF SUSPENSION E-MAILED
- 24 Jan 2025 — SUSPENSION LETTER WRITTEN
- 21 Jan 2025 — ASSIGNED TO EXAMINER